跳至主要内容
临床试验/NCT02816398
NCT02816398已完成不适用

Vessel-Select Catheter System Feasibility Clinical Trial

Medtronic Endovascular0 个研究点目标入组 26 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
26
主要终点
Number of Participants With Sufficient Patency for Clinical Access

研究概览

简要总结

Feasibility clinical study to evaluate the safety and effectiveness of the catheter system for the percutaneous creation of an arteriovenous fistula for patients with end stage renal disease requiring dialysis access.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients deemed medically eligible for AV fistula creation per institutional guidelines and/or clinical judgment
  • Patients diagnosed with chronic kidney disease classification stage IV or V
  • Adequate quality vein >= 2 mm with confirmed clinically significant outflow based on pre-operative assessment
  • Adequate quality radial artery >= 2 mm based on pre-operative assessment
  • Adequate collateral arterial perfusion
  • Radial artery-adjacent vein proximity < = 1.5 mm
  • Able to provide informed consent
  • Able to travel to institution for follow up examination
  • Able to intraoperatively place an .014" guidewire in artery

排除标准

  • Suspected skin disease
  • Immunocompromised patients (e.g. HIV positive)
  • Edema of extremities
  • Current diagnosis of carcinoma
  • Pregnancy or currently breast feeding
  • Diagnosed hypercoaguable state
  • Active infection
  • Evidence of vascular disease at target site
  • Pre-existing vascular disease that could confound study results
  • Vessel tortuosity or spasm preventing placement of .014" guidewire

结局指标

主要结局

Number of Participants With Sufficient Patency for Clinical Access

时间窗: 6 weeks

Arteriovenous fistula is patent as determined by auscultation or ultrasound and eligible for maturation assistance to achieve clinical access flow rate.

Number of Patients Achieving Dialysis Access

时间窗: 6 weeks

Arteriovenous fistula is mature and patient has started dialysis using the fistula

Number of Patients on Dialysis Using the Arteriovenous Fistula or Has Adequate Access Flow Rate to Allow Dialysis

时间窗: 3 months

Arteriovenous fistula is mature or has achieved a minimum clinically acceptable access flow rate as determined by doppler ultrasound assessment to support dialysis

次要结局

  • Number of Patients Requiring Additional Interventions to Achieve Maturation and Dialysis Access(12 weeks)

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

相似试验

Catheter System Feasibility Clinical Trial | 临床试验